mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
AUY922 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.67 |
0.01 |